Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar ...
A new study led by Trinity College Dublin and the Global Brain Health Institute (GBHI) across five European countries is the largest randomised controlled trial to date evaluating the efficacy of a ...
After a series of setbacks for dalzanemdor, some analysts now expect that Sage won’t reach profitability for awhile — and only if its cost structure undergoes significant changes.
said in a new interview that the embattled rapper likely is not getting any “special treatment” at the notorious Metropolitan Detention Center in Brooklyn, NY. “His money and wealth won’t ...